Uraki, Ryuta http://orcid.org/0000-0003-0890-1922
Halfmann, Peter J.
Iida, Shun http://orcid.org/0000-0003-2258-9031
Yamayoshi, Seiya http://orcid.org/0000-0001-7768-5157
Furusawa, Yuri
Kiso, Maki
Ito, Mutsumi
Iwatsuki-Horimoto, Kiyoko http://orcid.org/0000-0002-8266-020X
Mine, Sohtaro
Kuroda, Makoto
Maemura, Tadashi
Sakai-Tagawa, Yuko
Ueki, Hiroshi http://orcid.org/0000-0002-6557-0771
Li, Rong
Liu, Yanan
Larson, Deanna
Fukushi, Shuetsu
Watanabe, Shinji
Maeda, Ken http://orcid.org/0000-0002-3488-5439
Pekosz, Andrew http://orcid.org/0000-0003-3248-1761
Kandeil, Ahmed http://orcid.org/0000-0003-3253-6961
Webby, Richard J. http://orcid.org/0000-0002-4397-7132
Wang, Zhongde http://orcid.org/0000-0003-2441-4729
Imai, Masaki http://orcid.org/0000-0001-6988-1975
Suzuki, Tadaki
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
Article History
Received: 3 July 2022
Accepted: 25 October 2022
First Online: 2 November 2022
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation and Fuji Rebio. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.